NeuroVive Pharmaceutical AB ROIC
Cos'è ROIC di NeuroVive Pharmaceutical AB?
ROIC di NeuroVive Pharmaceutical AB è -152.24%
Qual è la definizione di ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC di aziende nel Health Care settore su OTC rispetto a NeuroVive Pharmaceutical AB
Cosa fa NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Aziende con roic simili a NeuroVive Pharmaceutical AB
- Predictmedix ha ROIC di -154.59%
- Helius Medical Technologies ha ROIC di -154.03%
- Titan Medical ha ROIC di -153.87%
- Cardinal Resources ha ROIC di -153.72%
- Ecc Ventures 3 Corp ha ROIC di -153.21%
- Thin Film Electronics ASA ha ROIC di -152.63%
- NeuroVive Pharmaceutical AB ha ROIC di -152.24%
- URA Plc ha ROIC di -152.11%
- Josemaria Resources ha ROIC di -151.90%
- Canadian Cannabis ha ROIC di -151.48%
- Ximen Mining ha ROIC di -150.81%
- Euro Sun Mining ha ROIC di -150.66%
- Eskay Mining ha ROIC di -150.63%